ClinConnect ClinConnect Logo
Search / Trial NCT04978545

The Effect of Ca(OH)2 in Apical Periodontitis

Launched by SEYDA ERSAHAN, DDS, PHD · Jul 24, 2021

Trial Information

Current as of May 28, 2025

Completed

Keywords

ClinConnect Summary

Eligibility criteria The study population consisted of 16 patients (6 women and 10 men, aged 19-63 years, mean age 34.43) presenting to the endodontic clinic at Istanbul Medipol University Dental School, for nonsurgical endodontic retreatment of teeth with apical periodontitis lesions. Sixteen previously root canal-treated teeth exhibiting clinical and radiographic evidence of chronic apical periodontitis lesions were included in this study. Radiographically, the diameter of the periapical radiolucency ranged from 2 to 7 mm. Teeth with post-treatment apical periodontitis had endodontic ther...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • root canal-treated teeth exhibiting clinical and radiographic evidence of chronic apical periodontitis lesions
  • Teeth with post-treatment apical periodontitis had endodontic therapy completed more than 2 years earlier and required retreatment.
  • Radiographically, the diameter of the periapical radiolucency ranged from 2 to 7 mm.
  • Termini of the root canal fillings ranged from 0-4 mm short of the radiographic apex, with no overfilling.
  • The teeth had intact coronal restorations, with no obvious exposure of the root-filling material to the oral cavity.
  • Selected teeth had enough crown structure for adequate isolation with a rubber dam and showed an absence of periodontal pockets or attachment level deeper than 4 mm.
  • Exclusion Criteria:
  • teeth from patients who had received antibiotics within the previous 3 months or who had any general disease, teeth that could not be properly isolated with rubber dam, teeth with absence of coronary sealing, teeth with periodontal pocket depth \>4 mm; and teeth with crown/root fracture. Only one tooth was included from each patient.

About Seyda Ersahan, Dds, Phd

Dr. Seyda Ersahan, DDS, PhD, is a distinguished clinical trial sponsor with extensive expertise in dental medicine and research methodologies. With a robust academic background and a commitment to advancing oral health, Dr. Ersahan leads innovative clinical trials aimed at exploring new treatments and technologies in dentistry. Her collaborative approach and dedication to evidence-based practices ensure that trials are designed and executed with the highest standards of scientific rigor, ultimately contributing to the enhancement of patient care and outcomes in the dental field.

Locations

Istanbul, Esenler, Turkey

Patients applied

0 patients applied

Trial Officials

Seyda Ersahan, Assoc.Prof.

Principal Investigator

IstanbulMedipol University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials